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The relation between ankle-brachial index (ABI) and coronary artery disease 
severity and risk factors: 











  BACKGROUND: The current study aims to determine the relation between ankle–brachial 
index (ABI) and angiographic findings and major cardiovascular risk factors in patients with 
suspected coronary artery diseases (CAD) in Isfahan. 
 METHODS:  In this cross-sectional descriptive-analytic research, patients with suspected CAD 
were studied. Characteristics of studied subjects including demographics, familial history, past 
medical history and atherosclerotic risk factors such as diabetes mellitus, hypertension, 
hyperlipidemia and smoking were obtained using a standard questionnaire. ABI was measured 
in all studied patients. ABI ≤ 0.9 (ABI+) was considered as peripheral vessel disease and ABI > 
0.9 (ABI-) was considered as normal. Then, all studied patients underwent coronary artery 
angiography. The results of the questionnaire and angiographic findings were compared in ABI+ 
and ABI- g r o u p s .  D a t a  w e r e  a n a l y z e d  b y  S P S S  1 5  u s i n g  A N O V A ,  t - t e s t ,  S p e a r m a n ' s  r a n k  
correlation coefficient, and discriminant analysis. 
 RESULTS: In this study, 125 patients were investigated. ABI ≤ 0.9 was seen in 25 patients (20%). 
The prevalence of ABI+ among men and women was 25.9% and 7.5%, respectively (P = 0.01). The 
prevalence of atherosclerotic risk factors was significantly higher in ABI+ patients than in ABI- 
ones (P < 0.05). ABI+ patients had more significant stenosis than ABI- ones. The mean of 
occlusion was significantly higher in ABI+ patients with left main artery (LMA), right coronary 
artery (RCA), left anterior descending artery (LAD), diagonal artery 1 (D1) and left circumflex 
artery (LCX) involvements (P < 0.05). 
  CONCLUSION: The findings of this research indicated that ABI could be a useful method in 
assessing both the atherosclerotic risk factors and the degree of coronary involvements in 
suspected patients. However, in order to make more accurate decisions for using this method in 
diagnosing and preventing CAD, we should plan further studies in large sample sizes of general 
population. 
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Introduction 
Atherosclerosis, the most common cause of mortality 
and morbidity worldwide, is considered a generalized 
process which affects coronary, cerebral, and 
peripheral arteries of the lower extremities.1 
  An important issue in clinical practice is coronary 
artery involvements of the disease due to their related 
high rate of complications and mortality.2 
  Evidence indicated the relation between peripheral 
arterial disease (PAD) and occurrence of 
cardiovascular disease and coronary events in patients 
with or without known coronary artery disease 
(CAD). Moreover, PAD is associated with an 
increased incidence of multivessel and obstructive 
CAD. The mentioned relationship is independent of 
the presence of other cardiovascular risk factors.3 
  In most cases, PAD is asymptomatic and therefore 
underdiagnosed. The clinical presentations of PAD in 
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minority of patients are intermittent claudication, rest 
pain and ulcer. Both symptomatic and asymptomatic 
PAD patients are at risk of cardiovascular disease and 
related mortality. Therefore, identifying patients with 
PAD especially those with asymptomatic disease in 
atherosclerotic disease is of high prognostic 
importance.4,5 
  The ankle-brachial index (ABI), calculated by 
dividing the higher systolic blood pressure of each 
ankle artery by the higher systolic blood pressure of 
the upper limbs,6 is a simple and non-invasive tool 
with high specificity and sensitivity for the diagnosis 
of PAD.7 Many studies have also reported its 
predictive value in CAD in patients suspected of 
having ischemic heart disease.8,9 
 Previous  investigations revealed an inverse 
relationship between ABI and cardiovascular and 
cerebrovascular diseases as well as their risk factors. 
They found ABI ≤ 0.9 as an indicator of PAD, 
cardiovascular disease and other atherosclerotic 
disease in different vascular areas. It is associated with 
a two- to three-fold increased risk of the mentioned 
disease morbidity and mortality.10,11 
  Considering the increasing burden of 
atherosclerotic disease and its mortality, and also the 
usefulness of non-invasive, easy and practical 
methods for identifying atherosclerotic risk factors 
for prevention or early treatment of atherosclerotic 
diseases, the aim of current study is to determine the 
relation between ABI with angiographic stenosis and 
major cardiovascular risk factors in patients with 
suspected CAD, in Isfahan. 
Materials and Methods 
In this cross-sectional descriptive-analytic study, 
patients with suspected CAD, who referred to Nour 
and Ali Asghar hospital for cardiac angiography 
during September-December 2008, enrolled. From 
the referred patients, 125 were selected by 
convenience method. 
  The study protocol was approved by the Ethics 
Committee of Isfahan University of Medical Sciences. 
Written informed consents were obtained from all 
studied patients. 
  Characteristics of the studied subjects including 
demographics, familial history, past medical history 
and atherosclerotic risk factors such as diabetes 
mellitus, hypertension, hyperlipidemia and smoking 
were obtained using a standard questionnaire.  
  Atherosclerotic risk factors were described as 
follows: 
  Smoking: Regular smoking of a tobacco product 
one or more times per day or have smoked in the past 
30 days prior to admission.12 
  Hyperlipidemia: Total cholesterol ≥ 200 mg/dl, 
LDL-cholesterol ≥ 130 mg/dl, HDL-cholesterol ≥ 40 
mg/dl in men, and ≥ 50 mg/dl in women, and 
triglyceride ≥ 200 mg/dl or using medicationss.13 
  Hypertension: Systolic blood pressure ≥ 140 
mmHg and/or diastolic blood pressure ≥ 90 mmHg 
and/or receiving antihypertensive treatment.14 
  Diabetes mellitus: Positive findings from any two 
of the following tests on different days: symptoms of 
diabetes mellitus plus casual plasma glucose 
concentration ≥ 200 mg/dl or fasting blood glucose 
≥ 126 mg/dl or 2-hour blood glucose 200 mg/dl 
and/or use of glucose lowering drugs.15 
  Patients with peripheral vascular disease and 
deformity in upper and lower limbs, unclear results of 
ABI and angiography were excluded. 
  A Madeco Biderectional Smatdop 30 
ultrasonography device (Japan) and a pneumatic cuff 
were used by a cardiologist to measure the brachial 
artery and ankle pressure waves. ABI was calculated 
as the ratio of the blood pressure in ankles to the 
blood pressure in the arms. 
ABI ≤ 0.9 (ABI+) was considered as peripheral vessel 
disease and ABI > 0.9 (ABI-) was considered as 
normal.16 
  Then all studied patients underwent coronary 
artery angiography.  
  Then, all patients underwent selective angiography 
via the femoral approach with a 5F or 6F catheter. 
Omnipaque 300 (iohexol 647 mg, trometamol 1.2 mg) 
was the contrast used in all of the cases. Two 
cardiologists evaluated each coronary angiography. 
Based on the angiographic findings, the participants 
were divided into normal group (with no coronary 
involvement) and CAD groups. CAD was defined as 
a stenosis of > 50% in the major coronary vessels. 
Coronary artery stenosis or CAD was evaluated and 
categorized as non-significant, significant and cut off 
if there was a stenosis < 75%, ≥ 75-99% and 100% in 
diameter, respectively.17 
  Angiographers made a subjective assessment of 
coronary vessels involvements including the left main 
artery (LMA), left circumflex coronary artery (LCX), 
right coronary artery (RCA), diagonal artery 1 (D1), 
diagonal artery 2 (D2) and large obtuse marginatus 
(OM). 
  The results of the questionnaire and angiographic 
findings were compared in ABI+ and ABI-groups. The 
data were analyzed by SPSS15 using ANOVA, t-test, 
Spearman's rank correlation coefficient (to determine 
the correlation of ABI and degree of coronary 
involvement), and discriminant analysis (to assess the 
predictive value of ABI for coronary involvement). A 
P-value less than 0.05 was considered significant. 
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Results 
In this study 125 patients [85 men (68%) and 40 
women (32%)] aging 32-80 years, suspected to CAD, 
were investigated. Mean age of studied patients was 
58.9 ± 10.0 years. 
  Twenty-five patients (20%) of the studied 
population had ABI < 0.9 (ABI+). The prevalence of 
ABI+ among men and women was 25.9% and 7.5%, 
respectively (P = 0.01). 
  Abnormal angiographic results were seen in 96% 
(24 persons) of the ABI+ group and 74% (74 persons 
of the ABI- group) (P = 0.01). The prevalence of 
atherosclerotic risk factors in ABI+ and ABI- patients 
is presented in Table 1. 
  The non-significant, significant and cut-off 
occlusion of different vessels according to 
angiographic findings in ABI+ and ABI- patients are 
presented in Table 2. 
  Mean ± SD of occlusion of different vessels 
according to angiographic findings in ABI+ and ABI- 
patients is presented in Table 3. 
 
Table 1. The prevalence of atherosclerotic risk factors in ABI+ and ABI- patients. 
Atherosclerotic risk factors 
ABI
+ patients 
N = 25 
ABI
-patients 
N = 100 
P-value 
Diabetes mellitus  10 (40%)  23 (23%)  0.04 
Hypertension 14  (56%)  32  (32%)  0.02 
Hyperlipidemia 11  (44%)  19  (19%)  0.005 
Smoking 13  (52%)  27  (27%)  0.01 
 
Table 2. Non-significant, significant and cut-off occlusion of different vessels according to angiographic 
findings in ABI+ and ABI- patients 
 ABI
+ patients  ABI
- patients P-value 
LMA
1   
non–significant 3  (12%)  3  (3%) 
0.01  significant  1 (4%)  1 (1%) 
cut-off 0 0
RCA
2      
non-significant 6  (24%)  17  (17%) 
0.001  significant  11 (44%)  14 (14%) 
cut-off  2 (8%)  8 (8%) 
LAD
3      
non–significant 3  (12%)  28  (28%) 
< 0.001  significant  17 (68%)  25 (25%) 
cut-off  2 (8%)  5 (5%) 
D1
4      
non-significant  1 (4%)  4 (4%) 
0.02  significant 9  (36%)  17  (17%) 
cut-off 0  0 
D2
5      
non-significant  2 (8%)  2 (2%) 
0.3  significant 0  7  (7%) 
cut-off 0  1  (1%) 
OM
6      
non-significant  2 (8%)  12 (12%) 
0.3  significant 4  (16%) 13  (13%)
cut-off 1  (4%)  0 
LCX
7      
non-significant 8  (32%) 15  (15%)
< 0.001  significant  11 (44%)  11 (11%) 
cut-off 2  (8%)  2  (2%) 
1- Left Main Artery; 2- Right Coronary Artery; 3- Left Anterior Descending Artery; 4- Diagonal Artery 1;   
5- Diagonal Artery 2; 6- Large Obtuse Marginatus Artery; 7-
 Left Circumflex Artery. 
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Table 3. Mean ± SD of occlusion of different vessels according to angiographic findings in ABI+ and 
ABI- patients. 
 ABI
+ patients  ABI
- patients  P-value 
LMA
1  10 ± 24.7  1.5 ± 8.75  0.006 
RCA
2  58.8 ± 37.1  28.5 ± 38.1  0.001 
LAD
3  76.4 ± 30.6  41.1 ± 38.5  0.001 
D1
4  33.2 ± 42.2  16.2 ± 32.1  0.02 
D2
5  4.4 ± 15.2  7.8 ± 24.1  0.4 
OM
6  22.2 ± 37.1  16.9 ± 30.7  0.4 
LCX
7  36.1 ± 31.5  19.1 ± 32.4  0.0001 
1-  Left Main Artery 
2-  Right Coronary Artery
 
3-  Left Anterior Descending Artery
 
4-  Diagonal Artery 1
 
5-  Diagonal Artery 2
 
6-  Large Obtuse Marginatus Artery
 
7-  Left Circumflex Artery 
 
Discussion 
In this study, the relation between angiographic 
findings and ABI in patients suspected to CAD was 
evaluated. The results indicated that the prevalence of 
atherosclerotic risk factors was significantly higher in 
ABI+ patients than in ABI- ones. Regarding coronary 
artery involvement, ABI+  patients had more 
significant stenosis than ABI- ones and the mean 
occlusion was significantly higher in ABI+  patients 
with LMA, RCA, LAD, D1 and LCX involvements. 
  In the present study, 20% of the subjects had ABI 
≤ 0.9 which was higher significantly in men than in 
women. The prevalence of ABI+  among high risk 
subjects, identified by general medical practice, has 
been reported to be 25-30% which is increased by 
age.18 The results of the current study regarding the 
prevalence of ABI+ was in line with other studies, but 
the age of ABI+ and ABI- patients was not 
significantly different. It may be a result of studying a 
selective group of patients. 
  There are different results regarding gender 
difference of ABI+. Our results were in line with the 
study of Papamicha et al., which similarly studied 165 
patients referred for elective coronary angiography.19 
Ramos et al. have reported similar results, whereas in 
the study of Taylor-Piliae et al. in Arizona, the 
prevalence of ABI+ was similar in both sexes.20 
C o n s i d e r i n g  t h e  h i g h  r a t e  o f  C A D  i n  m e n ,  t h e s e  
findings could be explained. However, in the USA, 
Sadrzadeh Rafie et al. studied the effect of sex 
differences on the prevalence of peripheral artery 
disease in patients referred for elective coronary 
angiography and showed that though the prevalence 
of CAD and its severity is lower in women, PAD is 
more prevalent among them. This was not in 
agreement with traditional cardiovascular disease risk 
factors or CAD severity.21 Therefore, it seems that 
more studies with larger sample size are needed for 
more conclusive results. 
  As mentioned, several studies reported that 
patients with PAD are at a higher risk of adverse 
cardiovascular events and other atherosclerotic 
diseases. ABI ≤ 0.9 has widely been used as an 
indicator of PAD and adjunct to the office-based 
assessment of cardiovascular risk in high-risk 
population. It is also associated with increased risk of 
cardiovascular and all-cause death.11,22,23 
  In a systematic review, Doobay et al. determined 
the sensitivity and specificity of ABI in predicting 
future cardiovascular events. They concluded that 
though ABI ≤ 0.9 is highly specific but not sensitive 
in this regard, it is considered a useful cardiovascular 
events risk prediction tool, especially in selected 
populations due to its simple assessment.24 
  In a study in Taiwan, Chang et al. studied the 
usefulness of ABI to predict the complex and diffuse 
coronary lesions in patients undergoing coronary 
angiography. They indicated that from atherosclerotic 
risk factors, diabetes, hypertension and smoking were 
significantly higher in ABI+ patients. Furthermore, 
compared to the control group, the ABI+ patients had 
more critical and stenotic lesions which were difficult 
to manipulate. Accordingly, they recommended to use 
this simple, inexpensive and well-established index 
not only for diagnosing PAD, but also for predicting 
diffuse and complex lesion subtypes which would be 
useful in treatment procedures during hospitalization 
and the follow-up period after subsequent 
interventions.25 
  Papamicha et al. reported similar findings 
regarding the use of ABI as the main variables for 
predicting the extent and severity of coronary disease 
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especially in male patients and those with diabetes and 
high levels of HDL cholesterol.19 
  In the current study, the prevalence of all studied 
risk factors was significantly higher in ABI+ patients 
than ABI- ones. Though we did not study the 
correlation between ABI and studied variables in men 
and women separately, Mc Dermott et al. have 
reported more significant relationships between 
mentioned variables in men than in women.26 
  There was not any study evaluating the relation 
between ABI and involvements of different vessels, as 
we did in the present study, but Sukhija et al. studied 
the prevalence of left main coronary artery disease, of 
three- or four-vessel coronary artery disease, and of 
obstructive coronary artery disease in patients with and 
without peripheral arterial disease undergoing coronary 
angiography for suspected coronary artery disease. 
They indicated that PAD patients had a higher 
prevalence of left main CAD (18% vs. < 1%), 3- or 4-
vessel CAD (63% vs. 11%) and obstructive CAD (98% 
vs. 81%) comparing with those without PAD. 
Moreover, in agreement with our study, they reported a 
higher prevalence of smoking, hypertension, diabetes 
mellitus, and dyslipidemia in patients with PAD than 
those without PAD.27 
  In this study, compared with ABI- patients, the 
degree of occlusion in different involved vessels and 
also the mean of stenosis were significantly higher in 
ABI+ patients, for all vessels except for D2 and OM, 
i.e. the most important arteries that are involved in 
CAD have more significant stenosis in ABI+ patients. 
  In contrast to our results, in a study in Lohare, 
Hakeem et al. have reported that from 41 patients 
only 3 had ABI ≤ 0.9 and all 3 had triple vessel 
disease. They concluded that there was not a direct 
association between ABI and significant CAD 
because only 3 patients out of 22 with triple vessel 
disease had an ABI ≤ 0.9. However, they indicated an 
approximately log linear relationship between ABI 
and CAD risk which means that the average CAD 
risk increased significantly at ABI values ≤ 1.0 and 
declined at values > 1.0.28 
  In conclusion, the findings of this research have 
indicated that ABI could be a useful method in 
assessing both the atherosclerotic risk factors and the 
degree of coronary involvement in suspected patients. 
However, making more accurate decisions for using 
this method in diagnosing and preventing CAD needs 
further studies with large sample sizes of general 
population. It is recommended to evaluate the 
relation between different levels of ABI, especially 
ABI > 1.4, which was not investigated properly, and 
the risk of atherosclerotic risk factors especially novel 
risk factors such as CRP, homocysteine and LPa.29,30 
Recent studies have suggested that an ABI of >1.4, as 
a marker of calcified, non-compressible arteries, could 
also predict an increased risk of cardiovascular 
events.29 
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